Compound ID | 501

Update compound information

PD 0199646

Class: Quinolone

Agent Type: Synthetic; Small molecule; Direct acting;
Spectrum of activity: Gram-negative
Mechanism of action: DNA synthesis inhibitor. Bacterial topoisomerase inhibitor
Institute where first reported: Parke-Davis Pharmaceutical (Pfizer, USA)
Year first mentioned: 2000
Development status: Experimental
Chemical structure(s):
Click here for structure editor
Molecular weight: 394.2
Iso. SMILES: BrC1=CC2=C3C(=C1)C(N(C(C3=CC(F)=C2N4CC[C@H](N)C4)=O)O)=O
InChI Key: DSTSHLKOISRTOW-QMMMGPOBSA-N
Can. SMILES: C1CN(C[C@H]1N)C2=C(C=C3C4=C(C=C(C=C42)Br)C(=O)N(C3=O)O)F
InChI: InChI=1S/C16H13BrFN3O3/c17-7-3-9-13-10(4-7)15(22)21(24)16(23)11(13)5-12(18)14(9)20-2-1-8(19)6-20/h3-5,8,24H,1-2,6,19H2/t8-/m0/s1
External links:

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.